⚠️Uptrend Under PressureSevere risk · 99·Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY)Full briefing →Jul 28
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence
AI output is commentary, not scanner evidence or a sizing recommendation.
Price$13.54Jul 27 close
52W High$13.60-0.4%
52W Low$5.69
Wks Since High3w
Base Depth-1.0%
Tight Wks12
BaseB1
SMA 50$13.45
SMA 200$9.47
Avg Vol2,734,026
RS Rank79
RS vs High-2.3%
RS Slope+0.2% ▲
Grp Rank#16/64
ADR%0.3%
ATR(14)$0.04 (0.3%)
Rel Vol (today)0.97×
Vol PaceN/A
U/D Vol1.50
A/D Days21A / 13D
A/D RatingA+
VDU Bars0/10 d
Power Trend30d
Earnings
7d
$5.69
$13.6099%
OGN Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Create a free account to load the full interactive chart for OGN.
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
Minervini B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger. Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it. Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry. Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended. Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop. Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
✓
Price above SMA 150 & 200$13.54 vs SMA150 $10.05 / SMA200 $9.47
✓
SMA 150 above SMA 200SMA150 $10.05 vs SMA200 $9.47
✓
SMA 200 trending upSlope +0.30 over 20 days
✓
SMA 50 above SMA 150 & 200SMA50 $13.45
✓
Price above SMA 50$13.54 vs SMA50 $13.45
✓
30%+ above 52W low+138.0% from $5.69
✓
Within 25% of 52W high-0.4% from $13.60
✓
RS score above 70RS 76
Fundamentals
52W Range
99%
Mkt Cap SEC
3.6B
EPS QoQ
+13%
Rev YoY
-3%
ROE
30%
Gross Margin
53%
D/E
11.49
EPS TTM
$0.72
P/E TTM
18.8x
Float
263M
Insider
No Buy
Company
Legend AI snapshot
Organon & Co.
OGN · NYSE
· Health Technology
· Pharmaceuticals: Major